TRIM22 was preferentially expressed in high grade gliomas (n = 82; HGG, WHO grade III-IV) compared with low grade gliomas (n = 30; LGG, WHO grade II; P < 0.001; Fig. 7a, b and Supplementary Table S4). The gene discussed is TRIM22; the disease is central nervous system cancer.